Endocrinology

Advanced Thyroid Cancer – State of the Art Management

Advanced Thyroid Cancer – State of the Art Management

Dr. ​Gregory ​Randolph​, MD, FACS, FACE, Director, Thyroid and Parathyroid Endocrine Surgical Division at Mass Eye and Ear talks​ about his study on Advanced Thyroid Cancer – State of the Art Management that was presented at the 2022 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) annual meeting.

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Cancer?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

With more than 25 years of experience in otolaryngology, Dr. Gregory Randolph specializes in thyroid and parathyroid surgery. He is a Professor of Otolaryngology at Harvard Medical School, the Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology, and a surgeon at Mass. Eye and Ear, where he also serves as the Director of the Thyroid and Parathyroid Endocrine Surgery Division. Dr. Randolph has a thyroid and parathyroid surgical practice, seeing patients and operating at both Mass. Eye and Ear and Mass General.

Dr. Randolph was the first otolaryngologist member of the American Association of Endocrine Surgeons (AAES), the first otolaryngologist member and council member of the International Association of Endocrine Surgeons (IAES), and the first otolaryngologist and United States surgeon to be board-certified in endocrine surgery in the European Union. Alongside Dr. Henning Dralle of Germany, he founded the Global International Neural Monitoring Study Group, which has generated multiple publications and standards guidelines for neural monitoring at thyroid surgery.

With more than 155 peer-reviewed publications, Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation, and monitoring during thyroid cancer surgery, with a concentration on the importance of laryngeal exams, the recognition of lymph node metastasis, and revision cancer surgery.

He has led thyroid surgical missions to St. Petersburg, Russia; Guangzhou, China; Kenya; rural India; and the Chernobyl region of the Ukraine. He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, Germany, Switzerland, and Russia.

Last updated: October 19, 2022

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.